MitoChem Therapeutics Granted FDA Orphan Drug Designation for Treatment of Retinitis Pigmentosa
CHARLESTON, SC / ACCESSWIRE / April 14, 2021 / MitoChem Therapeutics, Inc., a privately held company…
CHARLESTON, SC / ACCESSWIRE / April 14, 2021 / MitoChem Therapeutics, Inc., a privately held company…
Conversion rates more than double industry standards. FORT LAUDERDALE, FL / ACCESSWIRE / April 14,…
Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR…
SAN FRANCISCO, CA / ACCESSWIRE / April 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today…
The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of…
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April…
TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) (“Intellipharmaceutics” or the…
Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to…
TORONTO and HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Acquisition includes Dalitso’s 93,000 sq. ft. Facility and Nine Acres of Land Positioned to Efficiently…